Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice

Brain Research

Volumn 1222, Issue , 2008, Pages 207-213

  Cotel, Marie Caroline ^a   Bayer, Thomas A ^a   Wirths, Oliver ^a  

^a Alzheimer PhD Graduate School   (Germany)

Author keywords

Alzheimer; Amyloid; Dentate gyrus; Hippocampus; Neuron loss; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DENTATE GYRUS; GRANULE CELL; HIPPOCAMPUS; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; STEREOMETRY;

AGE FACTORS; AGING; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; CELL DEATH; DENTATE GYRUS; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; PRESENILIN-1; STEREOTAXIC TECHNIQUES;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 46749144083     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.05.052     Document Type: Article

References (35)

1. Bayer T.A., and Wirths O. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav. 7 Suppl 1 (2008) 6-11
2. Bayer T.A., Wirths O., Majtenyi K., Hartmann T., Multhaup G., Beyreuther K., and Czech C. Key factors in Alzheimer's disease: β-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 11 (2001) 1-11
3. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Reisberg B., De Leon M.J., and Miller D.C. Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging 17 (1996) 909-919
4. Calhoun M.E., Wiederhold K.H., Abramowski D., Phinney A.L., Probst A., Sturchler-Pierrat C., Staufenbiel M., Sommer B., and Jucker M. Neuron loss in APP transgenic mice. Nature 395 (1998) 755-756
5. Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O., van der Kolk N., Vingtdeux V., van de Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T.A., Benoit P., and Pradier L. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165 (2004) 1289-1300
6. Chevallier N.L., Soriano S., Kang D.E., Masliah E., Hu G., and Koo E.H. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am. J. Pathol. 167 (2005) 151-159
7. Donovan M.H., Yazdani U., Norris R.D., Games D., German D.C., and Eisch A.J. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J. Comp. Neurol. 495 (2006) 70-83
8. Feng R., Rampon C., Tang Y.P., Shrom D., Jin J., Kyin M., Sopher B., Miller M.W., Ware C.B., Martin G.M., Kim S.H., Langdon R.B., Sisodia S.S., and Tsien J.Z. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32 (2001) 911-926
9. Howlett D.R., Bowler K., Soden P.E., Riddell D., Davis J.B., Richardson J.C., Burbidge S.A., Gonzalez M.I., Irving E.A., Lawman A., Miglio G., Dawson E.L., Howlett E.R., and Hussain I. Abeta deposition and related pathology in an APP × PS1 transgenic mouse model of Alzheimer's disease. Histol. Histopathol. 23 (2008) 67-76
10. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., and Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56 (1997) 965-973
11. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 (1997) 493-495
12. Kuhn H.G., Dickinson-Anson H., and Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16 (1996) 2027-2033
13. Kwok J.B., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A., Hardy J., Fulham M.J., Nicholson G.A., Stell R., St George Hyslop P.H., Fraser P.E., Kakulas B., Clarnette R., Relkin N., Gandy S.E., Schofield P.R., and Martins R.N. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport 8 (1997) 1537-1542
14. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., and Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26 (2006) 10129-10140
15. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., and Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55 (2007) 697-711
16. Parent J.M., Elliott R.C., Pleasure S.J., Barbaro N.M., and Lowenstein D.H. Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann. Neurol. 59 (2006) 81-91
17. Regeur L., Jensen G.B., Pakkenberg H., Evans S.M., and Pakkenberg B. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol. Aging 15 (1994) 347-352
18. Ribe E.M., Perez M., Puig B., Gich I., Lim F., Cuadrado M., Sesma T., Catena S., Sanchez B., Nieto M., Gomez-Ramos P., Moran M.A., Cabodevilla F., Samaranch L., Ortiz L., Perez A., Ferrer I., Avila J., and Gomez-Isla T. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis. 20 (2005) 814-822
19. Rutten B.P., Wirths O., Van de Berg W.D., Lichtenthaler S.F., Vehoff J., Steinbusch H.W., Korr H., Beyreuther K., Multhaup G., Bayer T.A., and Schmitz C. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiol. Dis. 12 (2003) 110-120
20. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher III R.J., Kandel E.R., Duff K., Kirkwood A., and Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42 (2004) 23-36
21. Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H.W., Pradier L., and Bayer T.A. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 164 (2004) 1495-1502
22. Shen J., and Kelleher III R.J. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 403-409
23. Simic G., Kostovic I., Winblad B., and Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J. Comp. Neurol. 379 (1997) 482-494
24. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., Mann D.M., Hyman B.T., and Iwatsubo T. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 157 (2000) 331-339
25. Thompson A., Boekhoorn K., Van Dam A.M., and Lucassen P.J. Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?. Genes Brain Behav. 7 Suppl 1 (2008) 28-42
26. Urbanc B., Cruz L., Le R., Sanders J., Ashe K.H., Duff K., Stanley H.E., Irizarry M.C., and Hyman B.T. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13990-13995
27. Wang R., Dineley K.T., Sweatt J.D., and Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 126 (2004) 305-312
28. Wang R., Wang B., He W., and Zheng H. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J. Biol. Chem. 281 (2006) 15330-15336
29. Wen P.H., Hof P.R., Chen X., Gluck K., Austin G., Younkin S.G., Younkin L.H., DeGasperi R., Gama Sosa M.A., Robakis N.K., Haroutunian V., and Elder G.A. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp. Neurol. 188 (2004) 224-237
30. West M.J., Coleman P.D., Flood D.G., and Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 344 (1994) 769-772
31. West M.J., Kawas C.H., Stewart W.F., Rudow G.L., and Troncoso J.C. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging. 25 (2004) 1205-1212
32. Wirths O., and Bayer T.A. Early intraneuronal beta-amyloid pathology: Do transgenic mice represent valid model systems?. Open Aging J. 2 (2008) 7-12
33. Wirths O., Multhaup G., Czech C., Feldmann N., Blanchard V., Tremp G., Beyreuther K., Pradier L., and Bayer T.A. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 12 (2002) 275-286
34. Wirths O., Breyhan H., Schafer S., Roth C., and Bayer T.A. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease. Neurobiol. Aging 29 (2008) 891-901
35. Zhang C., McNeil E., Dressler L., and Siman R. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp. Neurol. 204 (2007) 77-87